ARCHIVES

DCE Advisors OK Recompetitions Worth $10 Mil.

This article is from The Cancer Letter archive.

Vol. 17 No. 29 | July 19, 1991

Download PDF Visit The Full Archive

Related Articles

Zerhouni Starts Work As NIH Director

May 24, 2002

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

NCI Staff Finishes Center Program Study, Submits Recommendations

February 25, 1977

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999